Middle East Fertility Society Journal
Middle East Fertility Society
Vol. 12, No. 3, 2007, pp. 193-197
Bioline Code: mf07037
Full paper language: English
Document type: Research Article
Document available free of charge
Middle East Fertility Society Journal, Vol. 12, No. 3, 2007, pp. 193-197
© Copyright 2007 - Middle East Fertility Society
Resistin as a predictor for ovarian response to clomiphene citrate in obese PCOS women|
Alaa, Nadin; Noah, Olfat; Rizk, Ahmed; Hamdy, Enas & Al-Inany, Hesham
Objective: to evaluate the value of resistin as a predictor of ovulation induction by clomiphene citrate in cases of PCOS.
Design: prospective, controlled clinical study
Setting: kasr Al-Aini Hospital
Materials and Methods: obese subfertile women with PCOS (BMI>30 kg/m2) received clomiphene citrate 50mg / 8hours from the third day of the cycle and for five days. Based on success of ovulation induction, women were divided into two groups: Group I who responded to CC and Group II: those who failed to respond to CC. Blood samples were collected on day 3 of the cycle and resistin, insulin and sugar were assayed .
Results: There was no significant difference between both groups regarding background characteristics, however, there was a significant difference regarding both BMI and resistin between both groups. Multiple linear regression showed a statistically significant value of resistin independent of that of BMI. The ROC curve showed a cut-off value of 4.78 for resistin with area under curve more than 78.9% and sensitivity 66.67% and specificity 82.4% to predict response to clomiphene citrate in obese PCOS women
Conclusion: in obese women, resistin may be of value in prediction of ovarian response to clomiphene citrate. This needs to be confirmed in further trials.
resistin, PCOS, obesity, clomiphene citrate
Alternative site location: http://www.mefsjournal.org